{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T09:49:31Z","timestamp":1763718571950,"version":"3.45.0"},"reference-count":28,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background and Clinical Significance: Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication of antiresorptive therapies such as Zolendronic acid, used for bone metastases. Its management remains challenging, with outcomes often unpredictable. Platelet-rich fibrin (PRF), rich in growth factors, has been proposed as a potential adjunct to surgical treatment, aiming to promote tissue regeneration and improve patient outcomes. Case Presentation: We reported three clinical cases of MRONJ in patients previously treated with Zolendronic acid. All patients underwent surgical sequestrectomy combined with A-PRF application. Disease stages ranged from early to advanced (stages I\u2013III). The success of treatment was evaluated based on how well the tissue healed, the extent of bone recovery, the amount of pain relief, and improvements in the patient\u2019s quality of life. The patient with early-stage MRONJ achieved complete healing. On the other hand, the patients with stage II and III disease showed only partial clinical improvement. Nevertheless, all cases demonstrated significant subjective reduction in pain and enhanced overall quality of life following PRF therapy. Conclusions: Early-stage intervention offers the best prognosis for MRONJ. While A-PRF may improve postoperative comfort and quality of life, its curative effect appears limited in advanced disease. This highlights the need for further randomized clinical trials to demonstrate the role of A-PRF in the treatment of MRONJ.<\/jats:p>","DOI":"10.3390\/reports8040240","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:44:53Z","timestamp":1763631893000},"page":"240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant A-PRF Application in Patients with Various Stages of Medication-Related Osteonecrosis of the Jaw (MRONJ): Case Series"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0069-6086","authenticated-orcid":false,"given":"Irina","family":"Vasi\u013c\u010denko","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery and Oral Medicine, Riga Stradi\u0146\u0161 University, 16 Dzirciema Str., LV-1007 Riga, Latvia"},{"name":"Centre of Oral and Maxillofacial Surgery, Pauls Stradi\u0146\u0161 Clinical University Hospital, 13 Pilso\u0146u Str., LV-1002 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0937-6157","authenticated-orcid":false,"given":"Ingr\u012bda","family":"\u010c\u0113ma","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery and Oral Medicine, Riga Stradi\u0146\u0161 University, 16 Dzirciema Str., LV-1007 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-4877","authenticated-orcid":false,"given":"Ieva","family":"B\u0101gante","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery and Oral Medicine, Riga Stradi\u0146\u0161 University, 16 Dzirciema Str., LV-1007 Riga, Latvia"},{"name":"Centre of Oral and Maxillofacial Surgery, Pauls Stradi\u0146\u0161 Clinical University Hospital, 13 Pilso\u0146u Str., LV-1002 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/oral2020014","article-title":"ONJ (MRONJ) Update 2021 Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs -Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event","volume":"2","author":"Fusco","year":"2022","journal-title":"Oral"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00432-010-0953-1","article-title":"Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws","volume":"137","author":"Koschinski","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/cncr.24119","article-title":"Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients","volume":"115","author":"Walter","year":"2009","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamaoncol.2020.6353","article-title":"Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer","volume":"7","author":"Unger","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.24.00171","article-title":"Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study","volume":"43","author":"Brunner","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kujanp\u00e4\u00e4, M., Vuollo, V., Tiisanoja, A., Laitala, M.L., S\u00e1ndor, G.K., and Karki, S. (2025). Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-02225-2"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1010-5182(06)60751-8","article-title":"Maxillary necrosis associated with biphosphonates. Diagnostic, clinical aspects and treatment","volume":"34","author":"Herencia","year":"2006","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Biphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1620\/tjem.247.75","article-title":"Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone","volume":"247","author":"Shibahara","year":"2019","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jormas.2019.02.011","article-title":"The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series","volume":"121","author":"Capella","year":"2020","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5507\/bp.2020.023","article-title":"The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patient\u2019s prospective study","volume":"165","author":"Zelinka","year":"2021","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech Repub."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"\u00d6zalp, \u00d6., Y\u0131ld\u0131r\u0131myan, N., \u00d6zt\u00fcrk, C., Kocabalkan, B., \u00b8Simsek Kaya, G., Sindel, A., and Altay, M.A. (2021). Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin. BMC Oral Health, 21.","DOI":"10.1186\/s12903-021-01965-7"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s10006-024-01291-6","article-title":"The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of Medication Related Osteonecrosis of the Jaw (MRONJ): A retrospective observational study","volume":"28","author":"Aslam","year":"2024","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/SCS.0000000000009161","article-title":"Use of Leukocyte-rich and Platelet-rich Fibrin (L-PRF) Adjunct to Surgical Debridement in the Treatment of Stage 2 and 3 Medication-Related Osteonecrosis of the Jaw","volume":"34","author":"Duygu","year":"2023","journal-title":"J. Craniofac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.joms.2022.06.026","article-title":"Medication-Related Osteonecrosis of the jaws in the Pediatric Population","volume":"80","author":"Neal","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chmielewski, M., Pilloni, A., and Adamska, P. (2024). Application of Advanced Platelet-Rich Fibrin in Oral and Maxillofacial Surgery: A Systematic Rewiew. J. Funct. Biomater., 15.","DOI":"10.3390\/jfb15120377"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Frutuoso, F., Frietas, F., Vilares, M., Francisco, H., Marques, D., Carames, J., and Moreira, A. (2024). A Medication-Related Osteonecrosis of the jaw: A Systematic Review of Case Reports and Case Series. Diseases, 12.","DOI":"10.3390\/diseases12090205"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.joms.2022.07.127","article-title":"Does the Addition of Platelet-Rich Fibrin in the Surgical Treatment of Medication-Related Osteonecrosis of the Jaws Impact Postoperative Disease Resolution?","volume":"80","author":"George","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.joms.2019.12.008","article-title":"The Effect of Platelet-Rich Fibrin Membrane in Surgical Therapy of Medication-Related Osteonecrosis of the Jaws","volume":"78","author":"Szentpeteri","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/SCS.0000000000005475","article-title":"Medication-Related Osteonecrosis of the Jaws. The Use of Leucocyte- Platelet-Rich Fibrin as an Adjunct in the Treatment","volume":"30","author":"Valente","year":"2019","journal-title":"J. Craniofac. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ijom.2016.04.010","article-title":"Surgical Treatment of osteonecrosis of the jaw with the use of the platelet -rich fibrin: A prospective study of 15 patients","volume":"45","author":"Hartlev","year":"2016","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","article-title":"Leucocyte-rich and platelet -rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: A prospective feasibility study","volume":"52","author":"Kim","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4103\/ijdr.IJDR_689_19","article-title":"Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report","volume":"31","author":"Giudice","year":"2020","journal-title":"Indian J. Dent. Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Blatt, S., Kr\u00fcger, M., K\u00e4mmerer, P.W., Thiem, D.G.E., Matheis, P., Eisenbei\u00df, A.-K., Wiltfang, J., Al-Nawas, B., and Naujokat, H. (2022). Non-Interventional Prospective Observational Study of Platelet Rich Fibrin as a Therapy Adjunctive in Patients with Medication-Related Osteonecrosis of the Jaw. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030682"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Adamska, P., Stasiak, M., Kobusinska, N., Bartmanski, M., Zedler, A., and Studniarek, M. (2025). Treatment of Medication-Related Osteonecrosis of the Jaws Without and With the Use of Advanced Platelet-Rich Fibrin: A Retrospective Clinical Study. J. Funct. Biomater., 16.","DOI":"10.3390\/jfb16050180"}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/8\/4\/240\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T09:44:32Z","timestamp":1763718272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/8\/4\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["reports8040240"],"URL":"https:\/\/doi.org\/10.3390\/reports8040240","relation":{},"ISSN":["2571-841X"],"issn-type":[{"type":"electronic","value":"2571-841X"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}